Key facts
- This page summarizes Ronald Peck's Form 4 filing for ARVINAS, INC. (ARVN).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 Aug 2023, 17:27.
Ronald Peck - 11 Aug 2023 Form 4 Insider Report for ARVINAS, INC. (ARVN)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- ARVN
- Reported as of
- 11 Aug 2023
- Net transaction value
- -$32,289
- SEC form
- 4
- Accepted by SEC
- 14 Aug 2023, 17:27:05 UTC
- Prior SEC filing
- 24 Feb 2023
- Next SEC filing
- 27 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Houston, as attorney-in-fact for Ronald Peck
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ronald Peck filed Form 4 for ARVINAS, INC. (ARVN) on 14 Aug 2023.
Change
- Previous filing in this sequence was filed on 24 Feb 2023.
- Current net transaction value: -$32,289.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ARVN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +4,010
- Change %
- +15%
- Price
- Shares after
- 31,289
- Date
- 11 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
ARVN
transaction
Common Stock
Sale
- Transaction value
- $32,289
- Shares
- -1,324
- Change %
- -4.2%
- Price
- $24.39
- Shares after
- 29,965
- Date
- 11 Aug 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ARVN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -4,010
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 11 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,010
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
Footnote F2
This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
Footnote F3
On July 29, 2019, the reporting person was granted 16,041 Restricted Stock Units, vesting in four equal annual installments beginning July 29, 2020.